
Thomas Vierbuchen
@tommyvierbuchen
Dev Bio Program + Center for Stem Cell Biology @MSKCancerCenter. Building next-gen cellular models to characterize polygenic basis of neurological disorders.
ID: 2696665235
http://scholar.google.com/citations?user=BJUpMksAAAAJ&hl=en 10-07-2014 23:01:51
2,2K Tweet
1,1K Followers
1,1K Following

In this joint collection Cell Stem Cell and StemCellReports (ISSCR) come together to share a collection on neuroscience models. Read now: hubs.li/Q02SV_kd0 Martin Pera



Exciting science and amazing scenery at The Jackson Laboratory Diversity in a Dish meeting this week.




Looking forward to ASHG this week! I will be presenting work led by @aabiddanda and Sara Carioscia using data from >100,000 IVF embryos to discover genetic variants influencing meiotic recombination and aneuploidy at the opening session on Tuesday evening. #ASHG24 ๐งฌ๐๏ธ



Incredibly proud of PhD student Hope Tanudisastro from my team, who just gave a fantastic #ASHG24 talk on the impact of tandem repeat variation on cell type-specific expression. Check out her preprint: biorxiv.org/content/10.110โฆ




Beautiful work by the Stadtfeld and Thomas Vierbuchen labs on the role of genetic variation on imprinting and dna methylation stability in mouse pluripotent stem cells cell.com/stem-cell-repoโฆ

New study shows genetic variation affects DNA #hypomethylation & imprint deregulation in naรฏve PSCs. Genetic variants may be potential biomarkers for epigenetically stable PSCs. ow.ly/aCVY50VilVY Weill Cornell Medicine Meyer Cancer Center Weill Cornell Medicine UMass Chan Medical School Memorial Sloan Kettering Cancer Center ISSCR


The latest work out of Weill Cornell Medicine proposes that genetic variants represent biomarkers to identify #pluripotent cell lines with desirable properties and may allow the targeted engineering of naive #PSCs with stable epigenomes. ๐ StemCellReports | bit.ly/3DHaeSR



